261 related articles for article (PubMed ID: 35767949)
1. Loss of Stathmin-2, a hallmark of TDP-43-associated ALS, causes motor neuropathy.
Krus KL; Strickland A; Yamada Y; Devault L; Schmidt RE; Bloom AJ; Milbrandt J; DiAntonio A
Cell Rep; 2022 Jun; 39(13):111001. PubMed ID: 35767949
[TBL] [Abstract][Full Text] [Related]
2. Loss of mouse Stmn2 function causes motor neuropathy.
Guerra San Juan I; Nash LA; Smith KS; Leyton-Jaimes MF; Qian M; Klim JR; Limone F; Dorr AB; Couto A; Pintacuda G; Joseph BJ; Whisenant DE; Noble C; Melnik V; Potter D; Holmes A; Burberry A; Verhage M; Eggan K
Neuron; 2022 May; 110(10):1671-1688.e6. PubMed ID: 35294901
[TBL] [Abstract][Full Text] [Related]
3. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.
Klim JR; Williams LA; Limone F; Guerra San Juan I; Davis-Dusenbery BN; Mordes DA; Burberry A; Steinbaugh MJ; Gamage KK; Kirchner R; Moccia R; Cassel SH; Chen K; Wainger BJ; Woolf CJ; Eggan K
Nat Neurosci; 2019 Feb; 22(2):167-179. PubMed ID: 30643292
[TBL] [Abstract][Full Text] [Related]
4. Reduced STMN2 and pathogenic TDP-43, two hallmarks of ALS, synergize to accelerate motor decline in mice.
Krus KL; Benitez AM; Strickland A; Milbrandt J; Bloom AJ; DiAntonio A
bioRxiv; 2024 Mar; ():. PubMed ID: 38562780
[TBL] [Abstract][Full Text] [Related]
5. Stathmin-2 loss leads to neurofilament-dependent axonal collapse driving motor and sensory denervation.
López-Erauskin J; Bravo-Hernandez M; Presa M; Baughn MW; Melamed Z; Beccari MS; Agra de Almeida Quadros AR; Arnold-Garcia O; Zuberi A; Ling K; Platoshyn O; Niño-Jara E; Ndayambaje IS; McAlonis-Downes M; Cabrera L; Artates JW; Ryan J; Hermann A; Ravits J; Bennett CF; Jafar-Nejad P; Rigo F; Marsala M; Lutz CM; Cleveland DW; Lagier-Tourenne C
Nat Neurosci; 2024 Jan; 27(1):34-47. PubMed ID: 37996528
[TBL] [Abstract][Full Text] [Related]
6. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.
Alhindi A; Shand M; Smith HL; Leite AS; Huang YT; van der Hoorn D; Ridgway Z; Faller KME; Jones RA; Gillingwater TH; Chaytow H
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12925. PubMed ID: 37465879
[TBL] [Abstract][Full Text] [Related]
8. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Melamed Z; López-Erauskin J; Baughn MW; Zhang O; Drenner K; Sun Y; Freyermuth F; McMahon MA; Beccari MS; Artates JW; Ohkubo T; Rodriguez M; Lin N; Wu D; Bennett CF; Rigo F; Da Cruz S; Ravits J; Lagier-Tourenne C; Cleveland DW
Nat Neurosci; 2019 Feb; 22(2):180-190. PubMed ID: 30643298
[TBL] [Abstract][Full Text] [Related]
9. Stathmin-2: adding another piece to the puzzle of TDP-43 proteinopathies and neurodegeneration.
Glass JD
J Clin Invest; 2020 Nov; 130(11):5677-5680. PubMed ID: 33074248
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of
Baughn MW; Melamed Z; López-Erauskin J; Beccari MS; Ling K; Zuberi A; Presa M; Gonzalo-Gil E; Maimon R; Vazquez-Sanchez S; Chaturvedi S; Bravo-Hernández M; Taupin V; Moore S; Artates JW; Acks E; Ndayambaje IS; Agra de Almeida Quadros AR; Jafar-Nejad P; Rigo F; Bennett CF; Lutz C; Lagier-Tourenne C; Cleveland DW
Science; 2023 Mar; 379(6637):1140-1149. PubMed ID: 36927019
[TBL] [Abstract][Full Text] [Related]
11. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
Agra Almeida Quadros AR; Li Z; Wang X; Ndayambaje IS; Aryal S; Ramesh N; Nolan M; Jayakumar R; Han Y; Stillman H; Aguilar C; Wheeler HJ; Connors T; Lopez-Erauskin J; Baughn MW; Melamed Z; Beccari MS; Olmedo Martínez L; Canori M; Lee CZ; Moran L; Draper I; Kopin AS; Oakley DH; Dickson DW; Cleveland DW; Hyman BT; Das S; Ertekin-Taner N; Lagier-Tourenne C
Acta Neuropathol; 2024 Jan; 147(1):9. PubMed ID: 38175301
[TBL] [Abstract][Full Text] [Related]
12. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
13. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
[TBL] [Abstract][Full Text] [Related]
14. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
[TBL] [Abstract][Full Text] [Related]
15. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice.
Wu LS; Cheng WC; Shen CK
J Biol Chem; 2012 Aug; 287(33):27335-44. PubMed ID: 22718760
[TBL] [Abstract][Full Text] [Related]
16. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia.
Prudencio M; Humphrey J; Pickles S; Brown AL; Hill SE; Kachergus JM; Shi J; Heckman MG; Spiegel MR; Cook C; Song Y; Yue M; Daughrity LM; Carlomagno Y; Jansen-West K; de Castro CF; DeTure M; Koga S; Wang YC; Sivakumar P; Bodo C; Candalija A; Talbot K; Selvaraj BT; Burr K; Chandran S; Newcombe J; Lashley T; Hubbard I; Catalano D; Kim D; Propp N; Fennessey S; ; Fagegaltier D; Phatnani H; Secrier M; Fisher EM; Oskarsson B; van Blitterswijk M; Rademakers R; Graff-Radford NR; Boeve BF; Knopman DS; Petersen RC; Josephs KA; Thompson EA; Raj T; Ward M; Dickson DW; Gendron TF; Fratta P; Petrucelli L
J Clin Invest; 2020 Nov; 130(11):6080-6092. PubMed ID: 32790644
[TBL] [Abstract][Full Text] [Related]
17. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
18. Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS.
Ebstein SY; Yagudayeva I; Shneider NA
Cell Rep; 2019 Jan; 26(2):364-373.e4. PubMed ID: 30625319
[TBL] [Abstract][Full Text] [Related]
19. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
20. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43
Chand KK; Lee KM; Lee JD; Qiu H; Willis EF; Lavidis NA; Hilliard MA; Noakes PG
FASEB J; 2018 May; 32(5):2676-2689. PubMed ID: 29295857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
